Trials / Completed
CompletedNCT04608513
A Placebo-controlled Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects
A Single-center, Double-blind, Randomized, Placebo-controlled Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Idorsia Pharmaceuticals Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A safety and tolerability study in healthy subjects including examination of how the body takes up, distributes, and gets rid of ACT-1014-6470
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACT-1014-6470 | Soft capsules for oral administration |
| DRUG | Placebo | Soft capsules for oral administration |
Timeline
- Start date
- 2020-11-16
- Primary completion
- 2021-09-20
- Completion
- 2021-09-20
- First posted
- 2020-10-29
- Last updated
- 2021-10-15
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04608513. Inclusion in this directory is not an endorsement.